Literature DB >> 7684437

Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes.

T J Schall1, K Bacon, R D Camp, J W Kaspari, D V Goeddel.   

Abstract

Lymphocyte trafficking is an essential process in immune and inflammatory functions which can be thought to contain at least two main components: adhesion and migration. Whereas adhesion molecules such as the selections are known to mediate the homing of leukocytes from the blood to the endothelium, the chemoattractant substances responsible for the migration of specific subsets of lymphocytes to sites of infection or inflammation are largely unknown. Here we show that two molecules in the chemokine (for chemoattractant cytokine) superfamily, human macrophage inflammatory protein 1 alpha (MIP-1 alpha) and MIP-1 beta, do not share identical attractant activities for lymphocyte subpopulations. When analyzed in vitro in microchemotaxis experiments, HuMIP-1 beta tends to attract CD4+ T lymphocytes, with some preference for T cells of the naive (CD45RA) phenotype. HuMIP-1 alpha, when tested in parallel with HuMIP-1 beta, is a more potent lymphocyte chemoattractant with a broader range of concentration-dependent chemoattractant specificities. HuMIP-1 alpha at a concentration of 100 pg/ml attracts B cells and cytotoxic T cells, whereas at higher concentrations (10 ng/ml), the migration of these cells appears diminished, and the migration of CD4+ T cells is enhanced. Thus, in this assay system, HuMIP-1 alpha and -1 beta have differential attractant activities for subsets of immune effector cells, with HuMIP-1 alpha having greater effects than HuMIP-1 beta, particularly on B cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684437      PMCID: PMC2191042          DOI: 10.1084/jem.177.6.1821

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

Review 1.  Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity.

Authors:  E C Butcher
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

Review 2.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

3.  RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils.

Authors:  P Kuna; S R Reddigari; T J Schall; D Rucinski; M Y Viksman; A P Kaplan
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

Review 4.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

5.  Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.

Authors:  G J Graham; E G Wright; R Hewick; S D Wolpe; N M Wilkie; D Donaldson; S Lorimore; I B Pragnell
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

6.  Monocyte chemotactic protein 1 is a potent activator of human basophils.

Authors:  S C Bischoff; M Krieger; T Brunner; C A Dahinden
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

7.  RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.

Authors:  A Rot; M Krieger; T Brunner; S C Bischoff; T J Schall; C A Dahinden
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

8.  Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8.

Authors:  A Walz; R Burgener; B Car; M Baggiolini; S L Kunkel; R M Strieter
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

9.  Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils.

Authors:  P Kuna; S R Reddigari; D Rucinski; J J Oppenheim; A P Kaplan
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

10.  Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.

Authors:  Y Kameyoshi; A Dörschner; A I Mallet; E Christophers; J M Schröder
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  144 in total

Review 1.  Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis.

Authors:  J Chesney; R Bucala
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  The CC chemokine MIP-1alpha induces a selective monocyte infiltration following intradermal injection into nonhuman primates.

Authors:  P J Didier; T J Paradis; R P Gladue
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

4.  Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis.

Authors:  A Diab; H Abdalla; H L Li; F D Shi; J Zhu; B Höjberg; L Lindquist; B Wretlind; M Bakhiet; H Link
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

6.  Intestinal intraepithelial lymphocytes have a promiscuous interleukin-8 receptor.

Authors:  A I Roberts; M Bilenker; E C Ebert
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

7.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

Authors:  R P Negus; G W Stamp; J Hadley; F R Balkwill
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

8.  Kinetic analysis and evaluation of the mechanisms involved in the resolution of experimental nontypeable Haemophilus influenzae-induced otitis media after transcutaneous immunization.

Authors:  Laura A Novotny; John D Clements; Lauren O Bakaletz
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

9.  The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.

Authors:  K Balakrishnan; M Peluso; M Fu; N Y Rosin; J A Burger; W G Wierda; M J Keating; K Faia; S O'Brien; J L Kutok; V Gandhi
Journal:  Leukemia       Date:  2015-04-28       Impact factor: 11.528

10.  Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1 alpha (MIP-1 alpha): contribution to the CD8+ alveolitis.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.